Novo Nordisk on Tuesday announced a partnership with OpenAI to deploy artificial intelligence across its business, spanning drug discovery, manufacturing and commercial operations, as the Danish drugmaker looks to sharpen its competitive edge in the fast-growing obesity drug market.The company said the collaboration would leverage OpenAI’s technology to analyse complex…
BP is heading into its first-quarter results with an unusually strong message on earnings, but also with a less…
Shares in LVMH were set to open lower on Tuesday after the company reported weaker first-quarter sales.According to a…
The United Airlines (UAL) and American Airlines (AAL) stocks will be in the spotlight today, April 14, as investors…
The Goldman Sachs stock price has rebounded and is moving closer to its all-time high as the company prepares…
The Nikkei 225 Index pulled back slightly on Monday, paring back some of the gains made in the past…
Asian markets opened the week on the back foot on Monday as a fresh oil shock renewed the anxieties…
The FTSE 100 Index futures pulled back on Monday as geopolitical tensions rose after the weekend talks between the…
Oracle’s brutal 2026 selloff is forcing Wall Street to answer a harder question than the usual buy-the-dip reflex.Shares of…